It has also clarified the important role of blocking ERK pathway in the treatment of pancreatic ductal adenocarcinoma (PDAC; Bryant et al., 2019) and also found that ERK has a two-way regulatory role in the pathophysiological of cardiac hypertrophy (Gallo et al., 2019). This evidence concerns the gene MAPK1 and pancreatic ductal adenocarcinoma.